曾志榮，男，主任醫(yī)師，教授，消化內(nèi)科主任，博士導(dǎo)師，博士學(xué)歷，畢業(yè)于1989年。醫(yī)療特長(zhǎng)：從事消化內(nèi)科臨床、科研和教學(xué)工作20余年，對(duì)消化系統(tǒng)疾病的診斷與治療有豐富的臨床經(jīng)驗(yàn)，尤擅長(zhǎng)炎癥性腸病（潰瘍性結(jié)腸炎、克羅恩?。?、幽門(mén)螺桿菌相關(guān)性疾?。ㄈ缏晕秆?、消化性潰瘍等）、胃食管反流病和胃腸動(dòng)力障礙性疾病的臨床診治。研究方向：（1）炎癥性腸病基礎(chǔ)及臨床研究；（2）幽門(mén)螺桿菌感染及其相關(guān)性疾??；（3）胃癌的遺傳易感性研究。?主要教育和工作經(jīng)歷：1984.9-1989.6: 江西醫(yī)學(xué)院臨床醫(yī)療系，獲醫(yī)學(xué)學(xué)士學(xué)位；1989.7-1993.8: 江西醫(yī)學(xué)院附屬醫(yī)院消化內(nèi)科，助教、住院醫(yī)師；1993.9-1996.6: 中山（醫(yī)科）大學(xué)附屬醫(yī)院消化內(nèi)科，獲醫(yī)學(xué)碩士學(xué)位；1996.9-1999.6: 中山（醫(yī)科）大學(xué)附屬醫(yī)院消化內(nèi)科，獲醫(yī)學(xué)博士學(xué)位；1999.7-目前：中山大學(xué)附屬醫(yī)院消化內(nèi)科，歷任講師、主治醫(yī)師，副教授、副主任醫(yī)師，教授、主任醫(yī)師，科副主任，碩士生導(dǎo)師?，F(xiàn)為科主任、博士生導(dǎo)師。社會(huì)兼職：（1）中華醫(yī)學(xué)會(huì)消化病學(xué)分會(huì)幽門(mén)螺桿菌學(xué)組副組長(zhǎng)；（2）廣東省醫(yī)學(xué)會(huì)消化病學(xué)分會(huì)副主任委，兼炎癥性腸病學(xué)組組長(zhǎng)；（3）廣東省中西醫(yī)結(jié)合學(xué)會(huì)脾胃分會(huì)常委近年發(fā)表的SCI論文：1.Incidence and clinical characteristics of inflammatory bowel disease in a developed region of Guangdong Province, China: a prospective population-based study. J Gastroenterol Hepatol. 2013 Jul; 28(7): 1148-53.2.Promoter hypermethylation of BCL6B gene is a potential plasma DNA biomarker for gastric cancer. Biomarkers. 2013 Dec; 18(8): 721-5.3.Epigenetic inactivation of BCL6B, a novel functional tumour suppressor for gastric cancer, is associated with poor survival. Gut. 2012 Jul; 61(7): 977-85.4.Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut. 2003 Dec; 52(12): 1684-9.5.Polymorphisms in prostate stem cell antigen gene rs2294008 increase gastric cancer risk in Chinese. Mol Carcinog. 2011 May; 50(5): 353-8.6.IL23R +2199A/C polymorphism is associated with decreased risk of certain subtypes of gastric cancer in Chinese: a case-control study. Cancer Epidemiol. 2011 Apr; 35(2): 165-9. 7.Association between the TGFB1 -509C/T and TGFBR2 -875A/G polymorphisms and gastric cancer: a case-control study. Oncol Lett. 2011 Mar; 2(2): 371-377.8.Potential implications of mesenchymal stem cells in cancer therapy. Cancer Lett. 2011 Jun 1; 305(1): 8-20. Review.9.IκBα polymorphisms were associated with increased risk of gastric cancer in a southern Chinese population: a case-control study. Life Sci. 2011 Apr 25; 88(17-18): 792-7. 10.Polymorphisms in interleukin-6-6331 influences the susceptibility of a Chinese population to gastric cancer. Cancer Invest. 2011 Oct; 29(8): 564-72.11.Association between polymorphisms in interleukin-17A and interleukin-17F genes and risks of gastric cancer. Int J Cancer. 2010 Jul 1; 127(1): 86-92.12.IL-1B-511 polymorphism is associated with increased risk of certain subtypes of gastric cancer in Chinese: a case-control study. Am J Gastroenterol. 2010 Mar; 105(3): 557-64.13.IkappaBalpha polymorphism at promoter region (rs2233408) influences the susceptibility of gastric cancer in Chinese. BMC Gastroenterol. 2010 Feb 5; 10:1514.Contribution of rs11465788 in IL23R gene to Crohn's disease susceptibility and phenotype in Chinese population. J Genet. 2009 Aug; 88(2): 191-6.15.Association of interleukin-17F 7488 single nucleotide polymorphism and inflammatory bowel disease in the Chinese population. Scand J Gastroenterol. 2009; 44(6): 720-6.專(zhuān)著：消化病臨床診斷與治療方案. 科學(xué)技術(shù)文獻(xiàn)出版社(2010)(副主編)醫(yī)學(xué)英文原版改編雙語(yǔ)教材《內(nèi)科學(xué)》. 科學(xué)出版社，編者，2007消化疾病診斷學(xué). 人民衛(wèi)生出版社, 編者, 2006內(nèi)科學(xué)習(xí)題集. 軍事醫(yī)學(xué)科學(xué)出版社, 編者, 2005消化系統(tǒng)疾病治療學(xué). 人民衛(wèi)生出版社, 編者, 2004?其他主要工作成績(jī)（比如情況）：（1）??? 廣東省自然科學(xué)獎(jiǎng)二等獎(jiǎng)（主持人），2011（2）??? 教育部科技進(jìn)步二等獎(jiǎng)（第二完），2009（3）??? 廣東省科技進(jìn)步二等獎(jiǎng)（參與），2004（4）??? 教育部提名的自然科學(xué)獎(jiǎng)一等獎(jiǎng)（參與），2003（5）? ?廣東省醫(yī)藥衛(wèi)生科技進(jìn)步一等獎(jiǎng)（參與），1996